04 67 20 77 30
contact@sensorion-pharma.com
Français
English
Our approach
Medical Need
Physiology
Restore / Treat / Prevent
Posters & Presentations
Pipeline
Team
Investors & Media
Investors
Press releases
Upcoming Events
Past Events
Career
Contact
Scientific Posters & Presentations
KOL webinar on POC Phase 2a study of SENS-401 to prevent residual hearing loss after cochlear implantation (July 5, 2023)
KOL Webinar Presentation Deck (powerpoint)
KOL Webinar Replay
ASGCT, 2023
An Integrated Adeno-Associated Vector Development Platform for Inner Ear Disorders
Preclinical development of an Adeno Associated Vector-Based Gene Therapy (SENS-501) for the Autosomal Recessive Non-Syndromic Deafness 9 (DFNB9)
Sensorion Gene Therapy R&D Day, April 6, 2023
Hearing Institute (Institut Pasteur)
R&D Day Presentation Deck (Powerpoint)
R&D Day Replay